Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
|
|
INFINITY PHARMACEUTICALS, INC. (INFI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 6% stake in Infinity Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 7.1% stake in Infinity Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Infinity Pharmaceuticals, Inc. |
| 01/18/2022 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 0.8% stake in INFINITY PHARMACEUTICALS, INC. |
| 02/12/2021 |
SC 13G/A
| Opaleye Management Inc. reports a 4.9% stake in INFINITY PHARMACEUTICALS, INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 0% stake in Infinity Pharmaceuticals, Inc. |
| 02/12/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 3.7% stake in Infinity Pharmaceuticals Inc |
| 02/08/2018 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 1.2% stake in Infinity Pharmaceuticals, Inc. |
| 07/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/30/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 07/11/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/11/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 08/09/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 06/27/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 04/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2012 |
SC 13G/A
| INFINITY PHARMACEUTICALS, INC. reports a 8% stake in INFINITY PHARMACEUTICALS INC |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/09/2010 |
SC 13G/A
| INFINITY PHARMACEUTICALS, INC. reports a 9.8% stake in Infinity Pharmaceuticals, Inc. |
| 03/31/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2009 |
SC 13G/A
| AMGEN INC reports a 0% stake in Infinity Pharmaceuticals, Inc. |
|
|